The Resilient Minds Program in Fire Departments

September 8, 2021 updated by: McMaster University

Assessing the Impact of the Resilient Minds Program in Fire Departments

The purpose of the study is to assess the impact of a mental health training program in volunteer and career firefighters.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Enrolling by invitation

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

THE PROBLEM: Firefighters are frequently exposed to distressing events, or critical incidents such as motor vehicle accidents, burnt bodies, failed rescue attempts, threats to one's own life, and completed suicides that can trigger posttraumatic stress reactions. Previous research show that first responders and other public safety personnel report frequent exposure to traumatic events and are at increased risk for mental health illnesses.

THE STUDY OBJECTIVE: To assess the impact of a mental health training program in volunteer and career firefighters.

THE STUDY SAMPLE: 600 firefighters: 300 Prince Edward Island volunteer or career firefighters, 300 Vancouver career firefighters

INTERVENTION: Vancouver Fire & Rescue Services and the Canadian Mental Health Association-Vancouver Fraser co-developed a new program called, "Resilient Minds-Building the Psychological Health of Fire Fighters." The Resilient Minds training will educate firefighters about the effects of trauma, how to recognize signs of mental health illness and how to access support after critical events. It also trains firefighters to recognize mental health and addictions in co-workers and how to facilitate their help-seeking.

OUTCOMES: The impact of the program will be assessed by pre- and post-program surveys, 3-month, 6-month, 12-month follow-up surveys.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Anticipated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
600

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Canada
    • British Columbia
      • Vancouver, British Columbia, Canada
        • Vancouver Fire and Rescue Services
    • Prince Edward Island
      • Charlottetown, Prince Edward Island, Canada
        • Charlottetown Fire Department
      • Mount Stewart, Prince Edward Island, Canada
        • East River Fire Department
      • Stratford, Prince Edward Island, Canada
        • Crossroads Fire Department
      • Summerside, Prince Edward Island, Canada
        • Summerside Fire Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years and older
  • can read, understand, speak English
  • career or volunteer firefighters in PEI participating in Resilient Minds program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
EXPERIMENTAL: Resilient Minds
Four comprehensive, skill-building learning modules in the areas of psychological trauma, mental health problems, resiliency and workplace stress.
Behavioral: Resilient Minds
The program is designed: 1) to decrease the risk of developing a stress disorder or other mental illnesses due to workplace incidents and/or unhealthy stress; 2) to mitigate the negative impacts of mental illness and trauma through early recognition and early intervention; 3) to support the public while on the frontline; and 4) to improve the psychological health of fire staff while cultivating resilience and enhancing quality of life.
Other Names:
  • Mental Resiliency

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Mental Health Knowledge
Time Frame: 0-12 months
Survey on mental health knowledge (unit of measure = 5-point Likert Scale, "Agree Strongly" to "Disagree Strongly")
0-12 months
Knowledge Retention
Time Frame: 0-12 months
Survey on retention of program material (unit of measure = 5-point Likert scale, "Not much" to "A Lot")
0-12 months
Work Stress
Time Frame: 0-12 months
Survey on factors that contribute to work stress (unit of measure = 5-point Likert scale, "Not at all" to "A Lot")
0-12 months
Impact on support levels
Time Frame: 0-12 months
Survey on program's impacts on peer supports and organizational culture (unit of measure = 5-point Likert scale, "No, it seems less supportive" to "Yes, it seems quite a bit more supportive")
0-12 months

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Self-perceived learning
Time Frame: 0-12 months
Survey on self-perceived learning about psychological trauma and/or mental health challenges (unit of measure = 4-point Likert scale, "Very true" to "Not true")
0-12 months
Helpfulness of training
Time Frame: 0-12 months
Survey of helpfulness of training (unit of measure = Yes or No response)
0-12 months
Utilization of training
Time Frame: 0-12 months
Survey on intent and actual usage of information or skills learned from program (unit of measure = Yes or No response)
0-12 months
Critical incidents exposure and impact
Time Frame: 0 months
Survey on exposures to difficult or stressful things (unit of measure = ratings of frequency and impact on life)
0 months
Resilience
Time Frame: 0-12 months
Survey on mental resiliency (unit of measure = 5-point Likert scale, "Strongly Agree" to "Strongly Disagree")
0-12 months

Other Outcome Measures

Other Outcome Measures

For clinical trials, a planned measurement described in the protocol that is used to determine the effect of an intervention/treatment on participants. For observational studies, a measurement or observation that is used to describe patterns of diseases or traits, or associations with exposures, risk factors, or treatment. Types of outcome measures include primary outcome measure and secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Traumatic Life Events Checklist
Time Frame: 3 months
Survey on lifetime experience with "difficult or stressful things"
3 months
PTSD Checklst
Time Frame: 0-12 months
Survey on PTSD symptoms over past month
0-12 months
Public Safety Officer Stress
Time Frame: 0-12 months
Survey on stress from being first responder (past 6 months)
0-12 months
Suicidal Behavioural
Time Frame: 0-12 months
Survey on suicidal behaviours
0-12 months
Anxiety
Time Frame: 0-12 months
Survey on anxiety symptoms (past 2 weeks)
0-12 months
Depression
Time Frame: 0-12 months
Survey on mood symptoms (past 2 weeks)
0-12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
McMaster University

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Canadian Institutes of Health Research (CIHR)
University of Western Ontario, Canada
Social Sciences and Humanities Research Council of Canada
Canadian Mental Health Association, Prince Edward Island
Canadian Mental Health Association, British Columbia
Canadian Mental Health Association, Vancouver-Fraser
Vancouver Fire and Rescue Services

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Amanda Brazil, MAEd, PhD, FIREWELL
  • Principal Investigator: Steve Fraser, Vancouver Fire & Rescue Services
  • Principal Investigator: Joy MacDermid, PhD, McMaster University & Western University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 25, 2018

Primary Completion (ACTUAL)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
June 30, 2021

Study Completion (ANTICIPATED)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 31, 2021

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
December 20, 2017

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 16, 2018

First Posted (ACTUAL)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 17, 2018

Study Record Updates

Last Update Posted (ACTUAL)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
September 9, 2021

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 8, 2021

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
September 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2017-4390-GRA

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trauma

Clinical Trials on Resilient Minds

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings